Cargando…

The Value of (68)Ga-PSMA PET/CT Following Equivocal (18)F-NaF PET/CT in Prostate Cancer Patients

Background: Inconclusive bone scans are a challenge but there is no consensus about follow-up imaging. We evaluated the use of (68)gallium-labelled prostate-specific membrane antigen ((68)Ga-PSMA) PET/CT if (18)F-sodium fluoride ((18)F-NaF) PET/CT was inconclusive. Methods: This retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madsen, Claus, Østergren, Peter, Haarmark, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344413/ https://www.ncbi.nlm.nih.gov/pubmed/32481743 http://dx.doi.org/10.3390/diagnostics10060352

Ejemplares similares

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

A randomised trial of [(18)F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
por: Buch‐Olsen, Karen Middelbo, et al.
Publicado: (2023)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Primary Staging of Prostate Cancer Patients with [(18)F]PSMA-1007 PET/CT Compared with [(68)Ga]Ga-PSMA-11 PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

The role of 18F–NaF PET/CT in metastatic bone disease
por: Araz, Mine, et al.
Publicado: (2015)

Prevalence of exclusive lower extremity metastases at (18)F-NaF PET/CT
por: Ordones, Monique Beraldo, et al.
Publicado: (2015)

Complementary findings on (18)F-FDG PET/CT and (18)F-NaF PET/CT in a patient with Erdheim-Chester disease
por: Sabino, Daniela, et al.
Publicado: (2017)

Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
por: Soydal, Çiğdem, et al.
Publicado: (2023)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

Comparison of (18)F-NaF PET/CT and (18)F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma
por: Zhang, Yin, et al.
Publicado: (2018)

Comparative Findings Between (68)Ga-PSMA and (18)F-FDG PET/CT for Hepatocellular Carcinoma
por: Erhamamcı, Seval, et al.
Publicado: (2020)

Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT
por: Valadares, Agnes Araujo, et al.
Publicado: (2016)

Comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Comparison of Bone Metastases between (18)F-NaF PET/CT, (18)F-NaF PET, and Planar (99m)Tc-MDP Bone Scintigraphy in Patients with Newly Diagnosed Nasopharyngeal Carcinoma
por: Wang, Dong, et al.
Publicado: (2022)

Diagnostic Performance of [(18)F]Fluorocholine and [(68)Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
por: Paymani, Zeinab, et al.
Publicado: (2020)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

(18)F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer
por: Rao, Liangjun, et al.
Publicado: (2016)

Cutaneous and Vascular Deposits of 18F-NaF by PET/CT in the Follow-Up of Patients with Pseudoxanthoma Elasticum
por: Lillo, Eugenia, et al.
Publicado: (2021)

Prostate Cancer Biochemical Recurrence Resulted Negative on [(68)Ga]Ga-PSMA-11 but Positive on [(18)F]Fluoromethylcholine PET/CT
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
por: Murtazalieva, Patimat, et al.
Publicado: (2022)

Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of (68)Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal (18)F-fluorocholine PET/CT: 1084 examinations
por: Chevalme, Yanna-Marina, et al.
Publicado: (2021)

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients
por: Dyrberg, Eva, et al.
Publicado: (2017)

Normal SUV Values Measured from NaF18- PET/CT Bone Scan Studies
por: Win, Aung Zaw, et al.
Publicado: (2014)

Assessment of different quantification metrics of [(18)F]-NaF PET/CT images of patients with abdominal aortic aneurysm
por: Akerele, Mercy I., et al.
Publicado: (2020)

(18)F-NaF PET/CT and Extraordinary Involvement: Non-calcific Brain Involvement in a Prostate Cancer Case
por: Korkmaz, Ulku, et al.
Publicado: (2020)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

(18)F-FDG and (18)F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
por: Reddy, Natasha, et al.
Publicado: (2023)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

Analysis of Pros and Cons in Using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
por: Maisto, Costantina, et al.
Publicado: (2022)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Can (18)F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Noninvasive Detection of Active Microcalcification in an Occlusive Peripheral Vascular Aneurysm Using (18)F-NaF PET/CT Imaging
por: Eisert, Susan Natalie, et al.
Publicado: (2020)

Application of F-18-Sodium Fluoride (NaF) Dynamic PET-CT (dPET-CT) for Defect Healing: A Comparison of Biomaterials in an Experimental Osteoporotic Rat Model
por: Cheng, Caixia, et al.
Publicado: (2014)

Quantitative [(99m)Tc]Tc-MDP SPECT/CT correlated with [(18)F]NaF PET/CT for bone metastases in patients with prostate cancer
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Specificity of (68)Ga-PSMA PET/CT for Prostate Cancer - Myths and Reality
por: Sasikumar, Arun
Publicado: (2017)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l15jiuh7n0n14ecgp7ep0d5eb5